# Gamma-linolenic Acid Supplementation Study

> **NCT04481724** · NA · COMPLETED · sponsor: **Virta Health** · enrollment: 302 (actual)

## Conditions studied

- Weight Trajectory

## Interventions

- **DIETARY_SUPPLEMENT:** gamma-linolenic acid
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT04481724
- **Lead sponsor:** Virta Health
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-22
- **Primary completion:** 2023-02-13
- **Final completion:** 2023-09-15
- **Target enrollment:** 302 (ACTUAL)
- **Last updated:** 2024-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04481724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04481724, "Gamma-linolenic Acid Supplementation Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04481724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*